Levothyroxine Sodium

NDC 63323-885 · Fresenius Kabi USA, LLC

FDA carries 3 listing records for this NDC; the most recent is shown.

Generic nameLevothyroxine Sodium

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)LEVOTHYROXINE SODIUM

Strength20 ug/mL

Pharmacologic classThyroxine [CS], l-Thyroxine [EPC]

Marketing categoryNDA

Packages

63323-885-10 — 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-10) / 5 mL in 1 VIAL, SINGLE-DOSE

63323-885-14 — 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-14) / 5 mL in 1 VIAL, SINGLE-DOSE

63323-885-12 — 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-12) / 5 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J0651 — Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg Medicare Part B payment limit (ASP + 6%): $6.84

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60846-803 — levothyroxine sodium, 60846-804 — levothyroxine sodium, 60846-805 — levothyroxine sodium, 60846-806 — levothyroxine sodium, 60846-807 — levothyroxine sodium, 60846-808 — levothyroxine sodium, 60846-809 — levothyroxine sodium, 60846-810 — levothyroxine sodium, 60846-811 — levothyroxine sodium, 60846-812 — levothyroxine sodium, 63323-890 — Levothyroxine Sodium, 63323-895 — Levothyroxine Sodium, 63629-2088 — Levothyroxine Sodium, 63629-2090 — Levothyroxine Sodium, 63629-2091 — Levothyroxine Sodium, 63629-2092 — Levothyroxine Sodium, 63629-2094 — Levothyroxine Sodium, 63629-8711 — levothyroxine sodium, 63629-8712 — levothyroxine sodium, 67046-0290 — Levothyroxine Sodium, +547 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.